https://www.selleckchem.com/pr....oducts/4-hydroxytamo
The A1C metric has been the gold standard for assessing glycemia for decades. This biologic assay, based on averaging, is fraught with limitations and may be giving way to more holistic approaches. This article reviews glycemic time in range as the new standard for assessing patients with continuous glucose monitoring data. Information from the International Consensus Group on Time in Range will be summarized.Continuous glucose monitoring is poised to radically change the treatment of diabetes and patient eng
Curtir
Comentario
Compartilhar
